[Tumor immunology].
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001667:Binding, Competitive; D002272:Carcinoembryonic Antigen; D002464:Cell Migration Inhibition; D002478:Cells, Cultured; D002860:Chromium Radioisotopes; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000139:chemically induced / Q000209:etiology / Q000276:immunology*; D009360:Neoplastic Cells, Circulating; D009858:Oncogenic Viruses / Q000276:immunology; D014181:Transplantation Immunology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D002272:Carcinoembryonic Antigen; D002860:Chromium Radioisotopes
Tumorimmunologie